Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
1.410
-0.140 (-9.03%)
Mar 31, 2025, 1:08 PM EDT - Market open

Company Description

Scienture Holdings, Inc. operates as health services IT company.

It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies.

Scienture Holdings, Inc. is headquartered in Tampa, Florida.

Scienture Holdings, Inc.
Scienture Holdings logo
Country United States
Founded 2010
IPO Date Feb 13, 2020
Industry Pharmaceutical Retailers
Sector Healthcare
Employees 19
CEO Surendra Ajjarapu

Contact Details

Address:
6308 Benjamin Rd, Suite 708
Tampa, Florida 33634
United States
Phone 800 261 0281
Website scienture.com

Stock Details

Ticker Symbol SCNX
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001382574
ISIN Number US80880X1046
SIC Code 2834

Key Executives

Name Position
Dr. Shankar Hariharan Ph.D. Founder and Chief Executive Officer of Scienture LLC and Director
Surendra K. Ajjarapu Chairman of the Board, Chief Executive Officer and Secretary
Prashant Patel R.Ph. President and Chief Operating Officer
Rahul Surana M.B.A., Ph.D. Executive Vice President and Chief Operating Officer of Scienture LLC
Michele Rath Senior Vice President and Chief Commercial Officer of Scienture LLC

Latest SEC Filings

Date Type Title
Mar 26, 2025 10-K Annual Report
Mar 21, 2025 8-K Current Report
Mar 13, 2025 8-K Current Report
Mar 10, 2025 8-K Current Report
Feb 24, 2025 424B3 Prospectus
Feb 18, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Feb 14, 2025 EFFECT Notice of Effectiveness
Feb 7, 2025 UPLOAD Filing
Feb 6, 2025 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 5, 2025 UPLOAD Filing